Soluble human fibroblast growth factor (FGF) -binding fusion proteins and a method of making these proteins are disclosed. Methods of using such fusion proteins to inhibit FGF binding to FGF receptors, to inhibit tumor cell proliferation in vitro and in vivo and to treat tumors in mammals are also disclosed.
